Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery

Conditions: Stress Urinary Incontinence, Surgical Incision, Pain Vulva

Sex: Female

Ages: 18 Years – N/A

Phase: PHASE3

Enrollment: 126

Sponsor: TriHealth Inc.

Location: United States

Summary

This study will compare the use of a dual-agent local analgesic (bupivacaine-meloxicam) for abdominal incisions in patients undergoing retropubic mid-urethral sling surgery to see if narcotic usage and pain are impacted.

Eligibility Criteria

Inclusion Criteria:undergoing retropubic mid-urethral sling surgery (with concomitant anterior repair or urethrocele repair)English as first languageExclusion Criteria:patients undergoing concomitant posterior repair, vaginal vault suspension, or any other intra-peritoneal surgeries including hysterectomyNSAID use within 7 days of surgerysteroid use within 10 daysdaily opioid use in the last 3 monthslong acting opioids within 3 daysany opioids within 24hpatients unable to consent for themselvespatients allergic to meloxicam or bupivacainepregnant or lactating patients

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05702827). StuddyBuddy aggregates publicly available trial information.